维普中文期刊产品整合服务
58篇 您的检索式:作者名="Addabbo"
    题名 作者 年代 出处 被引量
1Kidney-derived mesenchymal stem cel s contribute to vasculogenesis,angiogenesis and endothelial repair显示文摘Chen J Park HC Addabbo F 0,,07:1
2Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-kappaB/COX-2 signaling in human aortic endothelial cells显示文摘Addabbo F Nacci C De Benedictis L 2011Am J Physiol Endocrinol Metab2011,301,6:1
3Porcine-derived xenograft combined with a soft cortical membrane versus extraction alone for implant site development: a clinical study in humans显示文摘FESTA V M ADDABBO F LAINO L 2013Clin Implant Dent Relat Res2013,15,5:1
4Porcine-derived xenograft combined with a soft cortical membrane versus extraction alone for implant site development: a clinical study in humans显示文摘FESTA V M ADDABBO F LAINO L 2013Clin Implant Dent Relat Res2013,15,5:1
5Enhanced progenitor cell recruitment and endothelial repair after selective endothelial injuryof the mouse kidney 显示文摘Hohenstein B Kuo MC Addabbo F 2010Am J Physiol Renal Physiol2010,298,6:1
6Urine proteomics-prospects for future diagnostics显示文摘O'Riordan E Addabbo F Goligorsky MS 0,,1:1
7Mitochandria and reactive oxygen species显示文摘ADDABBO F MONTAGNANI M GOLIGORSKY MS 2009Hypertension2009,53,6:1
8Vascular actions of insulin with implications for endothelial dysfunction 显示文摘Potenza MA Addabbo F Montagnani M 2009Am J Physiol Endoerinol Metab2009,297,3:1
9Kidney-derived mesenchymal stem cells contribute to vaseulogenesis, angiogenesis and endotheli- al repair显示文摘Chen J Park HC Addabbo F 2008Kidney Int2008,74,7:1
10Kidney derived mesenchymal stem cells contribute to vasculogenesis,angiogenesis and endothelial repair显示文摘Chen J Park HC Addabbo F 2008Kidney Int2008,74,7:1
11Gender wage differentials by education in Italy 显示文摘ADDABBO T FAVARO D 2011Applied Economies2011,43,29:1
12Selective decrease in urinary aquaporin, 2 and increase in prostaglandin E2 excretion is associated with postobstructive polyuria in human congenital hydronephrosis 显示文摘Murer L Addabbo F Carmosino M 2004J Am Soc Nephrol2004,15,10:1
13Poverty Dynamics and Social Transfers in Italy in the Early 1990s 显示文摘ADDABBO T BALDINI M 2000International Journal of Manpower2000,21,34:1
14Evolutionary - new centromeres preferentially emerge within gene deserts显示文摘Lomiento M Jiang Z Addabbo P D 2008Ge- nome Biol2008,,9:1
15下肢截肢术后持续周围神经阻滞的作用:对幻肢综合征症状的影响显示文摘背景达90%的截肢者在肢体截肢术后会产生幻肢综合征(phantom limb syndroms,PLS)。尽管现在有很多不同的治疗方法,但没有一种是显著有效的。因此,我们评估了高浓度的局麻药在外周神经的持续输注对预防PLS的效果。方法在术前或术中给71例行下肢截肢术的患者放置一周围神经导管,通过弹力输注泵(非电子)在术中开始以5ml/h的速率持续输注0.5%罗哌卡因,并且持续到术后的第4—83天。在术后的第1天,第1、2、3、4周和第3、6、9、12月评估PLS。为了评估患者在接受罗哌卡因输注时PLS是否存在及其严重程度,在每次评估前中断6—12小时的给药(即直至肢体感觉的恢复)。幻肢痛和残肢痛的程度由5分级的VRS评分系统来评分,其中0分代表无疼痛,4分代表不能忍受的疼痛,而幻肢的感觉被记录为存在或者不存在。如果VRS评分大干1分或者有显著的幻肢感觉出现,罗哌卡因立即以5ml/h的速率重新开始输注。如果患者的VRS评分持续为0或1分并且无幻肢感觉达48小时,则输注完全停止并移除导管。结果局麻药的持续输注时间的中位数是30天(95%的可信区间,25-30天)。在术后第1天,73%的患者主诉有严重的或者不能忍受的疼痛(VRS评分大于2分)。但是,在12个月的评估期的最后患者“严重到不能忍受”的幻肢痛的发生率仅为3%。在第12个月末,患者VRS疼痛评分的百分比:84%的患者为0分,10%的患者为1分,3%的患者为2分,3%的患者为3分,没有患者为4分。但是,在12个月的评估期的最后仍有39%的患者有幻肢感觉。所有患者都能在家中应用这种弹力输注系统。结论术后予以0.5%的罗哌卡因于神经周的持续输注可能是下肢截肢术后治疗幻肢痛和幻肢感觉的有效方法。Battista Borghi, MD Marco D'Addabbo, MD Paul F. White, MD, PhD Pina Gallerani,RN Letizia Toccaceli, ND William Raffaeli, MD Andrea Tognu, MD Nicola Fabbri, MD and Mario Mercuri, MD 毛祖旻(译) 李士通(校) 2012麻醉与镇痛2012,8,3:1
16Enhanced progenitor cell recruitment and endothelial repair after selec- tive endothelial injury of the mouse kidney显示文摘HOHENSTEIN B KUO M C ADDABBO F 2010Am J Physiol Renal Physiol2010,298,6:1
17Vascular actions of insulin with implications for endothelial dysfunction显示文摘Potenza MA Addabbo F Montagnani M 2009Am J Physiol Endocrinol Metab2009,297,3:1
18Enhanced progenitor cell recruitment and endothelial repair after se- lective endothelial injury of the mouse kidney 显示文摘Hohenstein B Kuo MC Addabbo F 2010Am J Physiol Renal Physiol2010,298,6:1
19Porcine-derivedxenograft combined with a soft cortical membrane versusextraction alone for implant site development: a clinical studyin humans显示文摘Festa VM Addabbo F Laino L 2013Clin Implant Dent Relat Res2013,15,5:1
20Vascular actions of insulin with implications for endothelial dysfunction 显示文摘Potenza MA Addabbo F Montaguani M 2009Am J Physiol Endo- crinol Metab2009,297,3:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费